Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.
Srivastava IK, Stamatatos L, Kan E, Vajdy M, Lian Y, Hilt S, Martin L, Vita C, Zhu P, Roux KH, Vojtech L, C Montefiori D, Donnelly J, Ulmer JB, Barnett SW. Srivastava IK, et al. Among authors: hilt s. J Virol. 2003 Oct;77(20):11244-59. doi: 10.1128/jvi.77.20.11244-11259.2003. J Virol. 2003. PMID: 14512572 Free PMC article.
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.
Lian Y, Srivastava I, Gómez-Román VR, Zur Megede J, Sun Y, Kan E, Hilt S, Engelbrecht S, Himathongkham S, Luciw PA, Otten G, Ulmer JB, Donnelly JJ, Rabussay D, Montefiori D, van Rensburg EJ, Barnett SW. Lian Y, et al. Among authors: hilt s. J Virol. 2005 Nov;79(21):13338-49. doi: 10.1128/JVI.79.21.13338-13349.2005. J Virol. 2005. PMID: 16227256 Free PMC article.
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.
Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, Leung L, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L. Barnett SW, et al. Among authors: hilt s. J Virol. 2001 Jun;75(12):5526-40. doi: 10.1128/JVI.75.12.5526-5540.2001. J Virol. 2001. PMID: 11356960 Free PMC article.
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
Wen Y, Trinh HV, Linton CE, Tani C, Norais N, Martinez-Guzman D, Ramesh P, Sun Y, Situ F, Karaca-Griffin S, Hamlin C, Onkar S, Tian S, Hilt S, Malyala P, Lodaya R, Li N, Otten G, Palladino G, Friedrich K, Aggarwal Y, LaBranche C, Duffy R, Shen X, Tomaras GD, Montefiori DC, Fulp W, Gottardo R, Burke B, Ulmer JB, Zolla-Pazner S, Liao HX, Haynes BF, Michael NL, Kim JH, Rao M, O'Connell RJ, Carfi A, Barnett SW. Wen Y, et al. Among authors: hilt s. PLoS One. 2018 Apr 26;13(4):e0194266. doi: 10.1371/journal.pone.0194266. eCollection 2018. PLoS One. 2018. PMID: 29698406 Free PMC article.
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.
Zambonelli C, Dey AK, Hilt S, Stephenson S, Go EP, Clark DF, Wininger M, Labranche C, Montefiori D, Liao HX, Swanstrom RI, Desaire H, Haynes BF, Carfi A, Barnett SW. Zambonelli C, et al. Among authors: hilt s. PLoS One. 2016 Jul 21;11(7):e0157391. doi: 10.1371/journal.pone.0157391. eCollection 2016. PLoS One. 2016. PMID: 27442017 Free PMC article.
Identification of a circulating carbohydrate antigen as a highly specific and sensitive target for schistosomiasis serology.
Kildemoes AO, Veldhuizen T, Hilt ST, van Lieshout L, Supali T, Yazdanbakhsh M, Camprubí-Ferrer D, Muñoz J, Clerinx J, Harvey M, Codée J, Corstjens PLAM, van Dam GJ, Visser LG, Roestenberg M, van Diepen A, Hokke CH. Kildemoes AO, et al. Among authors: hilt st. J Clin Microbiol. 2025 Jan 13:e0100824. doi: 10.1128/jcm.01008-24. Online ahead of print. J Clin Microbiol. 2025. PMID: 39804062
Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection.
Koopman JPR, Houlder EL, Janse JJ, Lamers OA, Roozen GV, Sijtsma JC, Casacuberta-Partal M, Hilt ST, van der Stoep MYEC, van Amerongen-Westra IM, Brienen EA, Wammes LJ, van Lieshout L, van Dam GJ, Corstjens PL, van Diepen A, Yazdanbakhsh M, Hokke CH, Roestenberg M. Koopman JPR, et al. Among authors: hilt st. J Clin Invest. 2024 Dec 12:e185422. doi: 10.1172/JCI185422. Online ahead of print. J Clin Invest. 2024. PMID: 39666392 Free article.
73 results